[Oral, low-dosage methotrexate in chronic progressive multiple sclerosis. A preliminary critical analysis]

Nervenarzt. 1995 Aug;66(8):643-7.
[Article in German]
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / adverse effects
  • Male
  • Methotrexate / administration & dosage*
  • Methotrexate / adverse effects
  • Middle Aged
  • Multiple Sclerosis / drug therapy*
  • Neurologic Examination / drug effects
  • Prospective Studies

Substances

  • Immunosuppressive Agents
  • Methotrexate